Literature DB >> 3530155

Use of the donor specific transfusion protocol in living-unrelated donor-recipient combinations.

H W Sollinger, M Kalayoglu, F O Belzer.   

Abstract

The scarcity of suitable cadaver or living-related kidneys remains the major problem in renal transplantation. The use of the donor-specific transfusion protocol (DST) has allowed for the expansion of the donor pool to one- and two-haplotype mismatched living-related donor-recipient combinations. This study deals with the use of DST in living-unrelated donor-recipient combinations (LURD). The following 34 LURD combinations were entered: husband to wife; wife to husband; friend to friend; stepfather; brother-in-law and sister-in-law. Donor-specific sensitization occurred in 21%. Actuarial graft survival at 4 years is 92.6%, and patient survival is 100%. It is concluded that this study indicates that the results with the use of LURDs equal the results with living-related donors and, therefore, it is suggested that the use of LURDs can be considered in situations when a medically and ethically acceptable unrelated donor is available.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530155      PMCID: PMC1251284          DOI: 10.1097/00000658-198609000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation.

Authors:  R L Simmons; D M Canafax; D S Fryd; N L Ascher; W D Payne; D E Sutherland; J S Najarian
Journal:  Transplant Proc       Date:  1986-04       Impact factor: 1.066

2.  Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.

Authors:  H W Sollinger; M Deierhoi; M Kalayoglu; F O Belzer
Journal:  Transplant Proc       Date:  1986-04       Impact factor: 1.066

3.  Kidney transplantation from unrelated living donors. Time to reclaim a discarded opportunity.

Authors:  A S Levey; S Hou; H L Bush
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

4.  B-warm-positive crossmatch: a contraindication for transplantation in living related transplants undergoing donor-specific transfusion.

Authors:  J L Blank; G M Leo; H W Sollinger; N R Glass; F O Belzer
Journal:  Transplantation       Date:  1982-02       Impact factor: 4.939

5.  Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center.

Authors:  I J Miller; M Suthanthiran; R R Riggio; J J Williams; R A Riehle; E D Vaughan; W T Stubenbord; J Mouradian; J S Cheigh; K H Stenzel
Journal:  Am J Med       Date:  1985-08       Impact factor: 4.965

6.  Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood.

Authors:  C B Anderson; J D Tyler; G A Sicard; C K Anderman; G E Rodey; E E Etheredge
Journal:  Transplantation       Date:  1984-12       Impact factor: 4.939

7.  Donor-specific transfusions in unrelated and related HLA-mismatched donor-recipient combinations.

Authors:  H W Sollinger; W J Burlingham; E M Sparks; N R Glass; F O Belzer
Journal:  Transplantation       Date:  1984-12       Impact factor: 4.939

8.  The quality of life of hemodialysis and transplant patients.

Authors:  J P Johnson; C R McCauley; J B Copley
Journal:  Kidney Int       Date:  1982-09       Impact factor: 10.612

9.  The quality of life of patients with end-stage renal disease.

Authors:  R W Evans; D L Manninen; L P Garrison; L G Hart; C R Blagg; R A Gutman; A R Hull; E G Lowrie
Journal:  N Engl J Med       Date:  1985-02-28       Impact factor: 91.245

Review 10.  The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.

Authors:  A S Levey
Journal:  Arch Intern Med       Date:  1984-12
  10 in total
  6 in total

1.  Ethical decisions in the history of organ transplantation.

Authors:  A G Diethelm
Journal:  Ann Surg       Date:  1990-05       Impact factor: 12.969

2.  Kidney donation by living unrelated donors.

Authors:  P G Blake; C J Cardella
Journal:  CMAJ       Date:  1989-10-15       Impact factor: 8.262

3.  Use of donor-specific red blood cell transfusions for patients undergoing liver transplantation during the COVID-19 pandemic.

Authors:  Tao Lv; Xi Xu; Jiulin Song; Yifei Tan; Li Jiang; Jian Yang; Diao He; Lingxiang Kong; Weiyi Zhang; Panyu Chen; Qiwen Xiang; Tao Zhu; Hong Wu; Tianfu Wen; Jiayin Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2021-08       Impact factor: 7.293

4.  Living unrelated donor kidney transplantation between spouses.

Authors:  M Haberal; H Gulay; R Tokyay; Z Oner; T Enunlu; N Bilgin
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

5.  GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.

Authors:  Arthur J Matas; David M Vock; Hassan N Ibrahim
Journal:  Am J Transplant       Date:  2017-12-01       Impact factor: 8.086

6.  Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation.

Authors:  G Huang; N A Wilson; S R Reese; L M Jacobson; W Zhong; A Djamali
Journal:  Am J Transplant       Date:  2014-04-07       Impact factor: 8.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.